<DOC>
	<DOCNO>NCT01186133</DOCNO>
	<brief_summary>The objective study evaluate effectiveness safety new drug-eluting stent ( DES ) , compare first- , second- , third- , fourth-generation DES , `` real world '' daily practice .</brief_summary>
	<brief_title>Evaluation First , Second , New Drug-Eluting Stents Routine Clinical Practice</brief_title>
	<detailed_description>Consecutive patient receive New DES without mixture DES</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>coronary disease amenable percutaneous coronary intervention ( PCI ) clinical lesion limitation patient mixture several DES terminal illness life expectancy le 1 year patient cardiogenic shock</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>coronary disease</keyword>
	<keyword>drug elute stent</keyword>
</DOC>